Market News
Stay updated with the latest market trends, earnings, and economic indicators.
No Vaccine, Cross-Border Spread: WHO Declares Ebola Outbreak In Uganda, Congo A Global Health Emergency
The WHO urged countries bordering the DRC to activate emergency-response mechanisms, strengthen surveillance and conduct screening at border crossings and major internal transport routes.
Onesource Specialty Pharma gets government nod for Unit II expansion project
The company said Unit II is a flagship facility of the company and the proposed expansion represents a significant step in its growth strategy to enhance manufacturing capacities for servicing global partners.
Siemens eyes exit from cancer care chain American Oncology Institute
Siemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute. The deal is valued between ₹1,500-2,000 crore. Private equity funds and Healthcare Global Enterprises are potential bidders. AOI operates 16 hospitals in India and one in Sri Lanka. This move aligns with Siemens Healthineers' broader strategic reviews. The Indian cancer care market is experiencing significant growth and investment.
Charli XCX joins Nothing as shareholder and global brand ambassador
Consumer tech brand Nothing has named British pop star Charli XCX its first Global Brand Ambassador and a shareholder. This collaboration signifies Nothing's move to become a cultural brand, not just a hardware maker.
Hantavirus Scare: Fatal Obsession? How A Quest For Rare Species Led To 'Patient Zero's' Diagnosis
Health officials have rejected comparisons to COVID-19 and said that there is little risk to global public health from the Hantavirus.
Novartis expands India role in global drug development
Novartis is focusing on innovative medicines in India. The company is expanding its role in global drug development. Early-stage research is now happening in India. Novartis plans to launch more new medicines soon. This strategy reinforces its commitment to the Indian market and its significant employee base.
Which sectors saw the biggest FII inflows and outflows in April?
Foreign investors remained net sellers of Indian equities in April, though the pace of outflows eased sharply from March. FIIs turned buyers in sectors such as power, capital goods and metals, while financial services, healthcare, oil & gas and automobiles continued to witness heavy selling pressure amid global uncertainty.
Biocon shifts focus to margins, capacity utilisation after expansion phase
Biocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in global capabilities. The company reported a 13% revenue increase for FY26, though net profit saw a substantial decline. Biocon is also prioritizing sustainable, profitable growth and exploring in-licensing opportunities for its biosimilars portfolio.
Hantavirus: Two Indians Among Crew On Cruise Ship Hit By Deadly Outbreak
The deadly hantavirus outbreak on the MV Hondius cruise ship has triggered a global health alert.
'Hantavirus In 2026': Tweet Posted In 2022 Goes Viral Amid Global Health Scare
The death of three persons aboard a Dutch cruise ship have sparked global concern about a hantavrirus outbreak
Venus Remedies expands Latin America presence with Argentina nod for antibiotic
Venus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin America expansion. Argentina is a key market for critical care therapies. Ceftriaxone is vital for treating serious bacterial infections. This authorization strengthens Venus Remedies' global presence and commitment to accessible anti-infective treatments.
Reliance Industries shares in focus as Mukesh Ambani eyes satellite foray to take on Starlink
Reliance Industries is evaluating a multi-billion-dollar entry into satellite communications, focusing on low Earth orbit networks under Jio Platforms. The initiative aims to strengthen India’s strategic capabilities amid rising global competition, with discussions underway on technology partnerships, orbital slots and potential acquisitions as the company explores long-term opportunities in future.